EnteroMedics Inc. (ETRM) Stock Ratings


View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


Bearish

100% of 1 ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks
Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
danipre danipre 07/11/2014 1 month $1.55 $1.24 -19.94% 19 Active
Comments:
stoplose stoplose 05/15/2013 1 Year $0.88 $1.83 +108.21% -108 Ended
Comments: stock distressed
withmight withmight 05/15/2013 1 Year $0.88 $1.83 +108.21% -108 Ended
Comments: reverse split to short: downtrend disguised
marcelo aniloel zampolli marcelo aniloel zampolli 05/13/2013 3 months $0.85 $2.30 +169.73% 169 Ended
Comments:
university university 05/13/2013 1 Year $0.86 $1.76 +104.65% -104 Ended
Comments: Upcoming product launch won't be successful
everytrend everytrend 05/10/2013 1 Year $0.87 $1.77 +103.45% -103 Ended
Comments: Company has too many competitors
changetarget changetarget 05/10/2013 1 Year $0.87 $1.77 +103.45% -103 Ended
Comments: Upcoming product launch won't be successful
foollnever foollnever 05/09/2013 1 Year $0.88 $1.71 +94.32% -94 Ended
Comments: Just had a poor earnings report
nodummy nodummy 05/09/2013 1 Year $0.88 $1.71 +94.32% -94 Ended
Comments: Company has too many competitors
whatchoose whatchoose 05/08/2013 1 Year $0.86 $1.84 +114.15% -114 Ended
Comments: Projecting declines beyond the short-term
moderate moderate 05/08/2013 1 Year $0.86 $1.84 +113.51% -113 Ended
Comments: Company has too many competitors
outgetting outgetting 05/07/2013 1 Year $0.90 $1.85 +106.36% -106 Ended
Comments: Company is so much smaller and it has too many competitors
splitsoon splitsoon 05/07/2013 1 Year $0.90 $1.85 +106.36% -106 Ended
Comments: Enteromedics has too many competitors more solid
smaller smaller 05/06/2013 1 Year $0.88 $1.88 +113.64% -113 Ended
Comments: Upcoming product launch won't be successful
luca21 luca21 05/06/2013 1 Year $0.88 $1.88 +113.64% -113 Ended
Comments: Upcoming product launch won't be successful
freak freak 05/06/2013 1 Year $0.88 $1.88 +113.64% -113 Ended
Comments: This stock is overvalued
claimforwe claimforwe 05/06/2013 1 Year $0.88 $1.88 +113.64% -113 Ended
Comments: Company has too many competitors
trota trota 05/05/2013 1 Year $0.88 $1.88 +113.64% -113 Ended
Comments: This stock is overvalued
serpik serpik 05/05/2013 1 Year $0.88 $1.88 +113.64% -113 Ended
Comments: Company has too many competitors
federal loans and grants. federal loans and grants. 05/04/2013 1 Year $0.88 $1.88 +113.64% -113 Ended
Comments: Company has too many competitors
Displaying 1-20 of 25
<< first < previous 1 2 last >>

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.